ESC 365 - Myosin inhibitors as novel drugs for hypertrophic cardiomyopathy

ESC Professional Premium Access

Myosin inhibitors as novel drugs for hypertrophic cardiomyopathy

Session: New treatment targets for personalised therapy in genetic cardiomyopathies

Topic: Cardiomyopathies

Speaker: Professor J. van der Velden (Amsterdam, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Jolanda van der Velden

VU University Medical Centre, Amsterdam (Netherlands (The))

11 presentations

1 follower

4 more presentations in this session

Myosin activators for cardiomyopathy: all is not lost

Speaker: Professor Z. Papp (Debrecen, HU)

Targeting desmosomal adhesion to treat arrhythmogenic cardiomyopathy

Speaker: Assistant Professor C. Schinner (Bern, CH)

Targeting titin in dilated cardiomyopathy

Speaker: Professor W. Linke (Muenster, DE)

New treatment targets for personalised therapy in genetic cardiomyopathies - discussion

Access the full session

New treatment targets for personalised therapy in genetic cardiomyopathies

Speakers: Professor J. van der Velden, Professor Z. Papp, Assistant Professor C. Schinner, Professor W. Linke

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources